Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maximillian Zinner"'
Autor:
Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring
Publikováno v:
Digital Health, Vol 8 (2022)
Background Mobile health applications and their subset digital therapeutics—defined as evidence-based software interventions to prevent, manage, or treat a medical condition—offer great potential to improve patient care. However, such solutions o
Externí odkaz:
https://doaj.org/article/9e04aa627b8f4b228e6fc9baf0e1107f
Autor:
Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring
Publikováno v:
JMIR mHealth and uHealth, Vol 9, Iss 11, p e33012 (2021)
BackgroundIn October 2020, Germany became the first country, worldwide, to approve certain mobile health (mHealth) apps, referred to as DiGA (Digitale Gesundheitsanwendungen, in German, meaning digital health applications), for prescription with cost
Externí odkaz:
https://doaj.org/article/f67a1dfee06c4d99a3ef9a5e1ab282b4
Publikováno v:
International Journal of Medical Informatics. 174:105063
Autor:
Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring
Publikováno v:
Digital health. 8
Background Mobile health applications and their subset digital therapeutics—defined as evidence-based software interventions to prevent, manage, or treat a medical condition—offer great potential to improve patient care. However, such solutions o
Autor:
Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring
BACKGROUND In October 2020, Germany became the first country, worldwide, to approve certain mobile health (mHealth) apps, referred to as DiGA (Digitale Gesundheitsanwendungen, in German, meaning digital health applications), for prescription with cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a152ff00956b42ca8f51048d10f0febe
https://doi.org/10.2196/preprints.33012
https://doi.org/10.2196/preprints.33012
Autor:
Philip Boehme, Leonard Fehring, Jan P. Ehlers, Maximillian Zinner, Linn Bieske, Florian Dahlhausen
Publikováno v:
JMIR mHealth and uHealth
Background In October 2020, Germany became the first country, worldwide, to approve certain mobile health (mHealth) apps, referred to as DiGA (Digitale Gesundheitsanwendungen, in German, meaning digital health applications), for prescription with cos
Autor:
Philip Boehme, Florian Dahlhausen, Jan P. Ehlers, Linn Bieske, Maximillian Zinner, Leonard Fehring
Publikováno v:
Drug discovery today. 27(2)
Innovative pharmaceutical companies have started to explore quantum computing (QC). In this article, we provide a collective industry perspective from QC domain leaders at leading pharmaceutical companies. There are immediate nonfinancial benefits in
Autor:
Maximillian Zinner, Linn Bieske, Leonard Fehring, Florian Dahlhausen, Philip Boehme, Jan P. Ehlers
Publikováno v:
Drug discovery today. 26(7)
Quantum computing (QC) is expected to revolutionize drug research by performing tasks classical supercomputers are not capable of. However, practically useful quantum computation is not yet a reality, and thus it is still unclear when and whether QC